Adbry

Tralokinumab sold under the brand name Adtralza among others, is a human monoclonal antibody used for the treatment of atopic dermatitis.[1][3] Tralokinumab targets the cytokine interleukin 13.[5] The most common side effects include upper respiratory tract infections (colds and other infections of the nose and throat), reactions at the injection site, and redness and discomfort in the eye.[3] Tralokinumab was approved for medica... [wikipedia]